lonafarnib
Showing 1 - 22 of 22
Liver Disease, Hepatitis D Trial run by the NIDDK (Peg-interferon lambda, Lonafarnib, Ritonavir)
Completed
- Liver Disease
- Hepatitis D
- Peg-interferon lambda
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 6, 2021
Progeria, HGPS Trial (Lonafarnib)
Approved for marketing
- Progeria
- HGPS
- Lonafarnib
- (no location specified)
Apr 13, 2021
Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)
Active, not recruiting
- Malignant Supratentorial Neoplasm
- +2 more
- Lonafarnib
- Temozolomide
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2021
Liver Cancer Trial (gemcitabine HCl, lonafarnib, conventional surgery)
Withdrawn
- Liver Cancer
- gemcitabine hydrochloride
- +2 more
- (no location specified)
Jul 29, 2020
Hepatitis Delta Virus Trial in Worldwide (Lonafarnib, Ritonavir, PEG IFN-alfa-2a)
Recruiting
- Hepatitis Delta Virus
- Lonafarnib
- +4 more
-
Fresno, California
- +117 more
Sep 30, 2021
Progeria, Hutchinson-Gilford Syndrome Trial in Boston (Lonafarnib)
Completed
- Progeria
- Hutchinson-Gilford Syndrome
- Lonafarnib
-
Boston, MassachusettsChildren's Hospital Boston
Jun 11, 2019
Progeria, Hutchinson-Gilford Syndrome Trial in Boston (Lonafarnib, Zoledronic Acid, Pravastatin)
Completed
- Progeria
- Hutchinson-Gilford Syndrome
- Lonafarnib
- +2 more
-
Boston, MassachusettsChildren's Hospital Boston
Jun 11, 2019
Hepatitis D Trial run by the NIDDK (Lonafarnib, Ritonavir, Placebo)
Completed
- Hepatitis D
- Lonafarnib
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 27, 2018
Chronic Hepatitis D Infection Trial in Ankara (lonafarnib, Ritonavir, PEG IFN-a)
Completed
- Chronic Hepatitis D Infection
- lonafarnib
- +2 more
-
Ankara, TurkeyAnkara University Medical School
Jul 27, 2017
Chronic Hepatitis D Infection Trial in Ankara (lonafarnib, PEG IFN-a, Ritonavir)
Completed
- Chronic Hepatitis D Infection
- lonafarnib
- +2 more
-
Ankara, TurkeyAnkara University Medical School
Jan 18, 2017
Hepatitis D Trial run by the NIDDK (Lonafarnib, Placebo)
Completed
- Hepatitis D
- Lonafarnib
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 18, 2016
Brain and CNS Tumors Trial in Dijon, Nantes-Saint Herblain, Lausanne (lonafarnib, temozolomide)
Unknown status
- Brain and Central Nervous System Tumors
- lonafarnib
- temozolomide
-
Dijon, France
- +2 more
Feb 9, 2015
Lymphoma, Solid Tumor Trial in New York (fluorouracil, leucovorin calcium, lonafarnib)
Completed
- Lymphoma
- Unspecified Adult Solid Tumor, Protocol Specific
- fluorouracil
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Apr 2, 2013
Lung Cancer, Soft Tissue Sarcoma, Colorectal Carcinoma Trial in Atlanta (Lonafarnib, Docetaxel)
Terminated
- Lung Cancer
- +4 more
- Lonafarnib
- Docetaxel
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
Dec 17, 2012
Breast Cancer Trial in Brussels, Paris, Amsterdam (biological, drug, other)
Completed
- Breast Cancer
- trastuzumab
- +3 more
-
Brussels, Belgium
- +2 more
Sep 11, 2012
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Nijmegen (gemcitabine HCl,
Completed
- Bladder Cancer
- +2 more
- gemcitabine hydrochloride
- lonafarnib
-
Nijmegen, NetherlandsUniversity Medical Center Nijmegen
Sep 20, 2012
Epithelial Ovarian Cancer Trial in Germany (Lonafarnib)
Completed
- Epithelial Ovarian Cancer
- Lonafarnib
-
Berlin, Germany
- +22 more
Jun 28, 2012
Brain and CNS Tumors Trial in United States (lonafarnib)
Completed
- Brain and Central Nervous System Tumors
- lonafarnib
-
San Francisco, California
- +8 more
Oct 13, 2009